Individuals with the disorder carry a CDC73 gene mutation that predisposes them to early-onset primary hyperparathyroidism, ossifying jaw tumours, renal cystic disease, uterine tumours and parathyroid carcinomas. Here, CDC73 is linked to primary hyperparathyroidism.